Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel.

Research output: Contribution to journalArticle

37 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)679
Number of pages1
JournalAmerican Journal of Ophthalmology
Volume131
Issue number5
StatePublished - May 2001
Externally publishedYes

Fingerprint

Behcet Syndrome
Expert Testimony
Immunosuppressive Agents
Practice Guidelines
Guidelines
Pharmaceutical Preparations
interferon alfa-2a

ASJC Scopus subject areas

  • Ophthalmology

Cite this

@article{3211190709c841b09ba8cc28010cf9df,
title = "Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel.",
author = "Jabs, {D. A.} and Rosenbaum, {James (Jim)}",
year = "2001",
month = "5",
language = "English (US)",
volume = "131",
pages = "679",
journal = "American Journal of Ophthalmology",
issn = "0002-9394",
publisher = "Elsevier USA",
number = "5",

}

TY - JOUR

T1 - Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders

T2 - recommendations of an expert panel.

AU - Jabs, D. A.

AU - Rosenbaum, James (Jim)

PY - 2001/5

Y1 - 2001/5

UR - http://www.scopus.com/inward/record.url?scp=18044400399&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=18044400399&partnerID=8YFLogxK

M3 - Article

C2 - 11354352

AN - SCOPUS:18044400399

VL - 131

SP - 679

JO - American Journal of Ophthalmology

JF - American Journal of Ophthalmology

SN - 0002-9394

IS - 5

ER -